乐普医疗：公司注射用透明质酸钠复合溶液临床前动物实验已完成

Core Viewpoint - Lepu Medical (300003) is advancing its product pipeline with new medical aesthetic products, which are expected to enhance its business growth and market position [1] Product Development - The preclinical animal experiments for the sodium hyaluronate injection solution have been completed, and data is currently being organized for submission [1] - The cross-linked sodium hyaluronate gel containing poly-L-lactic acid is in the clinical trial phase [1] - The Thermage equipment and consumables have been submitted for market approval [1] Market Impact - The launch of these new products will improve the company's medical aesthetic product matrix and inject new momentum into business development [1] - Actual sales performance will be influenced by multiple factors, including macroeconomic conditions, market competition, and regulatory policies [1] - Future financial performance will be disclosed in subsequent financial reports from the company [1]